Virginia Retirement Systems Et Al Bristol Myers Squibb CO Transaction History

Virginia Retirement Systems Et Al

$14.2 Billion
Q2 2025

A detailed history of Virginia Retirement Systems Et Al transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 1,555,496 shares of BMY stock, worth $72.9 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

1,555,496

Previous 345,496 350.22%

Holding current value

$72.9 Million

Previous $21.1 Million 241.72%

% of portfolio

0.51%

Previous 0.16%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	BUY	$44.12 - $59.6 $53.4 Million - $72.1 Million	1,210,000 Added 350.22%	1,555,496 $72 Million
Q1 2025 Jul 16, 2025	SELL	$53.9 - $63.11 $43.1 Million - $50.5 Million	-800,500 Reduced 69.85%	345,496 $21.1 Million
Q3 2023 Jan 02, 2024	SELL	$57.89 - $64.73 $474,698 - $530,786	-8,200 Reduced 0.71%	1,145,996 $66.5 Million
Q2 2023 Aug 22, 2023	SELL	$63.71 - $70.74 $2.47 Million - $2.74 Million	-38,800 Reduced 3.25%	1,154,196 $73.8 Million
Q1 2023 Jul 11, 2023	SELL	$65.71 - $74.53 $3.83 Million - $4.35 Million	-58,304 Reduced 4.66%	1,192,996 $82.7 Million
Q4 2022 May 17, 2023	SELL	$68.48 - $81.09 $184,896 - $218,943	-2,700 Reduced 0.22%	1,251,300 $90 Billion
Q3 2022 May 16, 2023	SELL	$0.13 - $76.84 $23,738 - $14 Million	-182,600 Reduced 12.71%	1,254,000 $89.1 Billion
Q1 2022 Apr 21, 2022	SELL	$61.48 - $73.72 $1.3 Million - $1.56 Million	-21,100 Reduced 1.45%	1,436,600 $105 Million
Q3 2021 Oct 21, 2021	BUY	$59.17 - $69.31 $254,431 - $298,033	4,300 Added 0.3%	1,457,700 $86.3 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $9.88 Million - $10.8 Million	-159,600 Reduced 9.89%	1,453,400 $97.1 Million
Q1 2021 Apr 30, 2021	BUY	$59.34 - $66.74 $237,360 - $266,960	4,000 Added 0.25%	1,613,000 $102 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $5,774 - $6,543	-100 Reduced 0.01%	1,609,000 $99.8 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $57,430 - $63,640	-1,000 Reduced 0.06%	1,609,100 $97 Million
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $38,374 - $44,863	-700 Reduced 0.04%	1,610,100 $94.7 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $14.4 Million - $21 Million	311,200 Added 23.95%	1,610,800 $89.8 Million
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $4.99 Million - $6.51 Million	101,400 Added 8.46%	1,299,600 $83.4 Million
Q3 2019 Oct 22, 2019	BUY	$42.77 - $50.71 $1.21 Million - $1.44 Million	28,400 Added 2.43%	1,198,200 $60.8 Million
Q2 2019 Jul 26, 2019	BUY	$44.62 - $49.34 $825,470 - $912,790	18,500 Added 1.61%	1,169,800 $53.1 Million
Q1 2019 Apr 25, 2019	SELL	$45.12 - $53.8 $5.78 Million - $6.89 Million	-128,100 Reduced 10.01%	1,151,300 $54.9 Million
Q4 2018 Feb 07, 2019	BUY	$48.76 - $63.23 $35 Million - $45.4 Million	717,900 Added 127.85%	1,279,400 $66.5 Million
Q3 2018 Nov 02, 2018	BUY	$55.19 - $62.25 $17.3 Million - $19.6 Million	314,300 Added 127.14%	561,500 $34.9 Million
Q2 2018 Aug 03, 2018	BUY	$50.53 - $62.98 $12.5 Million - $15.6 Million	247,200 New	247,200 $13.7 Million

Others Institutions Holding BMY

# of Institutions

2,736

Shares Held

1.59B

Call Options Held

26M

Put Options Held

24.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.6B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Bristol Myers Squibb CO Transaction History